These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1977478)

  • 1. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors.
    Jabs BE; Bartsch AJ; Pfuhlmann B
    Eur Psychiatry; 2003 Jun; 18(4):177-81. PubMed ID: 12814851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study.
    Jabs BE; Berg D; Merschdorf U; Bartsch AJ; Pfuhlmann B
    Neuropsychobiology; 2001; 44(4):183-6. PubMed ID: 11702018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
    Dhopesh V; Macfadden A; Maany I; Gamble G
    Psychiatr Serv; 1997 Jan; 48(1):95-7. PubMed ID: 9117510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF; Labs SM; Casey DE
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and movement disorders in psychiatric patients.
    Menza MA; Grossman N; Van Horn M; Cody R; Forman N
    Biol Psychiatry; 1991 Jul; 30(2):109-15. PubMed ID: 1680470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handedness as a risk factor for neuroleptic-induced movement disorders.
    Brown KW; White T; Anderson F; McGilp R
    Biol Psychiatry; 1992 Apr; 31(7):746-8. PubMed ID: 1350923
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of manual dominance in patients with neuroleptic-induced movement disorders.
    Kern RS; Green MF; Satz P; Wirshing WC
    Biol Psychiatry; 1991 Sep; 30(5):483-92. PubMed ID: 1681944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of neuroleptic-induced parkinsonism.
    Hassin-Baer S; Sirota P; Korczyn AD; Treves TA; Epstein B; Shabtai H; Martin T; Litvinjuk Y; Giladi N
    J Neural Transm (Vienna); 2001; 108(11):1299-308. PubMed ID: 11768628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coincidence of schizophrenia and Parkinsonism: some neurochemical implications.
    Crow TJ; Johnstone EC; McClelleand HA
    Psychol Med; 1976 May; 6(2):227-33. PubMed ID: 1005563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic profile of cipazoxapine (Savoxepine), a new tetracyclic dopamine antagonist: clinical validation of the hippocampus versus striatum ratio model of dopamine receptors in animals. A preliminary report.
    Butler B; Bech P
    Pharmacopsychiatry; 1987 May; 20(3):122-6. PubMed ID: 2885867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long latency postural reflexes are under supraspinal dopaminergic control.
    Bloem BR; Beckley DJ; van Vugt JP; van Dijk JG; Remler MP; Langston JW; Roos RA
    Mov Disord; 1995 Sep; 10(5):580-8. PubMed ID: 8552109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-Hexane-induced parkinsonism: pathogenetic hypotheses.
    Pezzoli G; Antonini A; Barbieri S; Canesi M; Perbellini L; Zecchinelli A; Mariani CB; Bonetti A; Leenders KL
    Mov Disord; 1995 May; 10(3):279-82. PubMed ID: 7651443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics.
    Caligiuri MP; Lacro JP; Jeste DV
    J Clin Psychopharmacol; 1999 Aug; 19(4):322-8. PubMed ID: 10440459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.